Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3763250, 15 pages
http://dx.doi.org/10.1155/2016/3763250
Review Article

Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models

Institute of Pathophysiology, Semmelweis University, Budapest, Hungary

Received 13 July 2016; Revised 6 October 2016; Accepted 19 October 2016

Academic Editor: Jiang Du

Copyright © 2016 Norbert Kiss and Péter Hamar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Schilp, C. de Blok, M. Langelaan, P. Spreeuwenberg, and C. Wagner, “Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy,” BMC Nephrology, vol. 15, article 2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Ludwig and F. Keller, “Prophylaxis of contrast-induced nephrotoxicity,” BioMed Research International, vol. 2014, Article ID 308316, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Barrett and P. S. Parfrey, “Clinical practice. Preventing nephropathy induced by contrast medium,” The New England Journal of Medicine, vol. 354, no. 4, pp. 379–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ukaigwe, P. Karmacharya, M. Mahmood et al., “Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography,” American Journal of Cardiology, vol. 114, no. 9, pp. 1295–1302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Nicola, K. W. Shaqdan, K. Aran, M. Mansouri, A. Singh, and H. H. Abujudeh, “Contrast-induced nephropathy: identifying the risks, choosing the right agent, and reviewing effective prevention and management methods,” Current Problems in Diagnostic Radiology, vol. 44, no. 6, pp. 501–504, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Filiopoulos, D. Biblaki, and D. Vlassopoulos, “Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography,” Renal Failure, vol. 36, no. 6, pp. 979–986, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. Keaney, C. M. Hannon, and P. T. Murray, “Contrast-induced acute kidney injury: how much contrast is safe?” Nephrology Dialysis Transplantation, vol. 28, no. 6, pp. 1376–1383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. M. A. Mohammed, A. Mahfouz, K. Achkar, I. M. Rafie, and R. Hajar, “Contrast-induced nephropathy,” Heart Views, vol. 14, no. 3, pp. 106–116, 2013. View at Publisher · View at Google Scholar
  9. N. Katsiki, V. G. Athyros, A. Karagiannis, and D. P. Mikhailidis, “Contrast-induced nephropathy: an ‘all or none’ phenomenon?” Angiology, vol. 66, no. 6, pp. 508–513, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Calvin, S. Misra, and A. Pflueger, “Contrast-induced acute kidney injury and diabetic nephropathy,” Nature Reviews Nephrology, vol. 6, no. 11, pp. 679–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. P. Pendergrass and G. W. Chamberlain, “A survey of death and unfavorable sequelae following the administration of contrast media,” American College of Radiology, vol. 48, pp. 741–762, 1942. View at Google Scholar
  12. E. A. Merrill, Procedures in U.S. Hospitals 2003, Agency for Healthcare Research and Quality, Rockville, Md, USA, 2005.
  13. W. P. Burgess and P. J. Walker, “Mechanisms of contrast-induced nephropathy reduction for saline (NaCl) and sodium bicarbonate (NaHCO3),” BioMed Research International, vol. 2014, Article ID 510385, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Andreucci, T. Faga, A. Pisani, M. Sabbatini, D. Russo, and A. Michael, “Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors,” Scientific World Journal, vol. 2014, Article ID 823169, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. H. Au, A. Bruckner, S. M. Mohiuddin, and D. E. Hilleman, “The prevention of contrast-induced nephropathy,” Annals of Pharmacotherapy, vol. 48, no. 10, pp. 1332–1342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Naeem, G. E. McEnteggart, T. P. Murphy, E. Prince, S. Ahn, and G. Soares, “Fenoldopam for the prevention of contrast-induced nephropathy (CIN)—do we need more trials? A meta-analysis,” Clinical Imaging, vol. 39, no. 5, pp. 759–764, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Giacoppo, D. Capodanno, P. Capranzano, P. Aruta, and C. Tamburino, “Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization,” American Journal of Cardiology, vol. 114, no. 4, pp. 541–548, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Berns, “Nephrotoxicity of contrast media,” Kidney International, vol. 36, no. 4, pp. 730–740, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. A. N. Pavlidis, D. A. Jones, A. Sirker, A. Mathur, and E. J. Smith, “Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions,” American Journal of Cardiology, vol. 115, no. 6, pp. 844–851, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Golshahi, H. Nasri, and M. Gharipour, “Contrast-induced nephropathy; a literature review,” Journal of Nephropathology, vol. 3, no. 2, pp. 51–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. P. V. Prasad, A. Priatna, K. Spokes, and F. H. Epstein, “Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy,” Journal of Magnetic Resonance Imaging, vol. 13, no. 5, pp. 744–747, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zhou and S. Duan, “Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy,” Kidney and Blood Pressure Research, vol. 38, no. 2-3, pp. 165–171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. N. Heyman, C. Rosenberger, S. Rosen, and M. Khamaisi, “Why is diabetes mellitus a risk factor for contrast-induced nephropathy?” BioMed Research International, vol. 2013, Article ID 123589, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Pattharanitima and A. Tasanarong, “Pharmacological strategies to prevent contrast-induced acute kidney injury,” BioMed Research International, vol. 2014, Article ID 236930, 21 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Andreucci, T. Faga, A. Pisani, M. Sabbatini, and A. Michael, “Acute kidney injury by radiographic contrast media: pathogenesis and prevention,” BioMed Research International, vol. 2014, Article ID 362725, 21 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Vandenberghe, W. De Corte, and E. A. J. Hoste, “Contrast-associated AKI in the critically ill: relevant or irrelevant?” Current Opinion in Critical Care, vol. 20, no. 6, pp. 596–605, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Namasivayam, M. K. Kalra, W. E. Torres, and W. C. Small, “Adverse reactions to intravenous iodinated contrast media: a primer for radiologists,” Emergency Radiology, vol. 12, no. 5, pp. 210–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Burns, The US Market for Medical Imaging Contrast Media, Bio-Tech Systems, Las Vegas, Nev, USA, 2004.
  29. Radiopharmaceuticals: A Global Strategic Business Report, Global Industry Analysts, Inc, San Jose, Calif, USA, 2015.
  30. “Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) Global forecast to 2020,” Markets and markets, 2015.
  31. A. Kodama, H. Watanabe, R. Tanaka et al., “A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy,” Kidney International, vol. 83, no. 3, pp. 446–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Racz, E. Nagy, L. Rosivall, J. Szebeni, and P. Hamar, “Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus,” Lupus, vol. 19, no. 5, pp. 599–612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Andreucci, G. Fuiano, P. Presta et al., “Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells,” Biochemical Pharmacology, vol. 72, no. 10, pp. 1334–1342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Buyuklu, F. M. Kandemir, M. Ozkaraca et al., “Benefical effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney,” Human and Experimental Toxicology, vol. 34, no. 5, pp. 487–496, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Toprak, M. Cirit, M. Tanrisev et al., “Preventive effect of nebivolol on contrast-induced nephropathy in rats,” Nephrology Dialysis Transplantation, vol. 23, no. 3, pp. 853–859, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Saritemur, H. Un, E. Cadirci et al., “Tnf-α inhibition by infliximab as a new target for the prevention of glycerol-contrast-induced nephropathy,” Environmental Toxicology and Pharmacology, vol. 39, no. 2, pp. 577–588, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Su, W. Zou, W. Cai et al., “Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway,” European Journal of Pharmacology, vol. 723, no. 1, pp. 15–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. P. D. Jacobson and C. J. Rosenquist, “The introduction of low-osmolar contrast agents in radiology. Medical, economic, legal, and public policy issues,” The Journal of the American Medical Association, vol. 260, no. 11, pp. 1586–1592, 1988. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Bucher, C. N. De Cecco, U. J. Schoepf et al., “Is contrast medium osmolality a causal factor for contrast-induced nephropathy?” BioMed Research International, vol. 2014, Article ID 931413, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Biondi-Zoccai, M. Lotrionte, H. S. Thomsen et al., “Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis,” International Journal of Cardiology, vol. 172, no. 2, pp. 375–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. R. D. Moore, E. P. Steinberg, N. R. Powe et al., “Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial,” Radiology, vol. 182, no. 3, pp. 649–655, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. J. C. Jennette, V. D. D'Agati, J. L. Olson, and F. G. Silva, Heptinstall's Pathology of the Kidney, Edited by V. D. D. A. Charles Jennette, J. L. Olson and F. G. Silva, Wolters Kluwer, 7th edition, 2014.
  43. A. J. Monserrat and A. E. Chandler, “Effects of repeated injections of sucrose on the kidney. Histologic, cytochemical and functional studies in an animal model,” Virchows Archiv B: Cell Pathology, vol. 19, no. 1, pp. 77–91, 1975. View at Google Scholar
  44. G. Jost, H. Pietsch, J. Sommer et al., “Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats,” Investigative Radiology, vol. 44, no. 2, pp. 114–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Seeliger, M. Sendeski, C. S. Rihal, and P. B. Persson, “Contrast-induced kidney injury: mechanisms, risk factors, and prevention,” European Heart Journal, vol. 33, no. 16, pp. 2007–2015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. B. Persson, P. Hansell, and P. Liss, “Pathophysiology of contrast medium-induced nephropathy,” Kidney International, vol. 68, no. 1, pp. 14–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Ueda, A. Nygren, P. Hansell, and U. Erikson, “Influence of contrast media on single nephron glomerular filtration rate in rat kidney: a comparison between diatrizoate, iohexol, ioxaglate, and iotrolan,” Acta Radiologica, vol. 33, no. 6, pp. 596–599, 1992. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Edgren, L. Laasonen, P.-H. Groop, and L. Groop, “Iohexol and metrizoate in urography of insulin dependent patients,” Acta Radiologica, vol. 27, no. 3, pp. 265–267, 1986. View at Publisher · View at Google Scholar
  49. Å. Billström, S.-O. Hietala, F. Lithner, J. Merikanto, M. Wirell, and S. Wirell, “Nephrotoxicity of contrast media in patients with diabetes mellitus. A comparative urographic and angiographic study with iohexol and metrizoate,” Acta Radiologica, vol. 30, no. 5, pp. 509–515, 1989. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Tornquist and S. Holtas, “Renal angiography with iohexol and metrizoate,” Radiology, vol. 150, no. 2, pp. 331–334, 1984. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Solomon, “Contrast media: are there differences in nephrotoxicity among contrast media?” BioMed Research International, vol. 2014, Article ID 934947, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. P. M. Treuting, S. M. Dintzis, W. F. Charles, H. D. Liggitt, and K. S. Montine, Comparative Anatomy and Histology: A Mouse and Human Atlas, Elsevier/Academic Press, Boston, Mass, USA, 1st edition, 2012.
  53. L. Cullen-McEwen, M. R. Sutherland, and M. J. Black, “The human kidney, parallels in structure, spatial development, and timing of nephrogenesis,” in Kidney Development, Disease, Repair and Regeneration, L. Mh, Ed., pp. 27–37, Elsevier, Academic Press, 2015. View at Google Scholar
  54. M. A. Zimanyi, J. F. Bertram, and M. J. Black, “Nephron number and blood pressure in rat offspring with maternal high-protein diet,” Pediatric Nephrology, vol. 17, no. 12, pp. 1000–1004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. I. J. Murawski, R. W. Maina, and I. R. Gupta, “The relationship between nephron number, kidney size and body weight in two inbred mouse strains,” Organogenesis, vol. 6, no. 3, pp. 189–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. M. Sands and H. E. Layton, “The physiology of urinary concentration: an update,” Seminars in Nephrology, vol. 29, no. 3, pp. 178–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. S. Finlayson and C. A. Baumann, “Mouse proteinuria,” The American Journal of Physiology, vol. 192, no. 1, pp. 69–72, 1958. View at Google Scholar · View at Scopus
  58. “Proteinuria in rats and mice,” Nutrition Reviews, vol. 16, no. 11, pp. 337–340, 1958. View at Publisher · View at Google Scholar
  59. J. M. Alt, H. Hackbarth, F. Deerberg, and H. Stolte, “Proteinuria in rats in relation to age-dependent renal changes,” Laboratory Animals, vol. 14, no. 2, pp. 95–101, 1980. View at Publisher · View at Google Scholar · View at Scopus
  60. G. C. Hard and K. N. Khan, “A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment,” Toxicologic Pathology, vol. 32, no. 2, pp. 171–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. C. F. Pinto, M. Watanabe, and M. D. F. F. Vattimo, “Hydration and N-acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats,” Journal of Nephrology, vol. 21, no. 5, pp. 783–788, 2008. View at Google Scholar · View at Scopus
  62. K. N. M. Khan and C. L. Alden, “Kidney,” in Handbook of Toxicologic Pathology, W. M. Haschek, C. G. Rousseaux, and M. A. Wallig, Eds., pp. 1668–1724, Academic Press, San Diego, Calif, USA, 2001. View at Google Scholar
  63. V. Thongboonkerd, Renal and Urinary Proteomics: Methods and Protocols, Verlag GmbH & Co, 2010.
  64. J. B. Hook and R. S. Goldstein, Toxicology of the Kidney, Edited by J. B. Hook and R. S. Goldstein, Raven Press, New York, NY, USA, 2nd edition, 1993.
  65. S. N. Heyman, M. Brezis, C. A. Reubinoff et al., “Acute renal failure with selective medullary injury in the rat,” Journal of Clinical Investigation, vol. 82, no. 2, pp. 401–412, 1988. View at Publisher · View at Google Scholar · View at Scopus
  66. S. N. Heyman, M. Brezis, F. H. Epstein, K. Spokes, P. Silva, and S. Rosen, “Early renal medullary hypoxic injury from radiocontrast and indomethacin,” Kidney International, vol. 40, no. 4, pp. 632–642, 1991. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Agmon, H. Peleg, Z. Greenfeld, S. Rosen, and M. Brezis, “Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat,” The Journal of Clinical Investigation, vol. 94, no. 3, pp. 1069–1075, 1994. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Yokomaku, T. Sugimoto, S. Kume et al., “Asialoerythropoietin prevents contrast-induced nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 2, pp. 321–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Ari, Y. Yilmaz, A. E. Kedrah et al., “Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy,” American Journal of Nephrology, vol. 33, no. 3, pp. 269–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. H. T. Lee, M. Jan, C. B. Soo et al., “A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo,” American Journal of Physiology-Renal Physiology, vol. 290, no. 6, pp. F1367–F1375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Yao, H. Dong, C. X. Zhao et al., “Evaluation of urine fibrinogen level in a murine model of contrast-induced nephropathy,” Vascular, vol. 24, no. 3, pp. 273–278, 2016. View at Publisher · View at Google Scholar
  72. P. Tervahartiala, L. Kivisaari, R. Kivisaari, I. Virtanen, and C.-G. Standertskjöld-Nordenstam, “Contrast media-induced renal tubular vacuolization: a light and electron microscopic study on rat kidneys,” Investigative Radiology, vol. 26, no. 10, pp. 882–887, 1991. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Tervahartiala, L. Kivisaari, R. Kivisaari, T. Vehmas, and I. Virtanen, “Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Studies in dehydrated rats,” Nephron, vol. 76, no. 1, pp. 96–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Yoshioka, A. Fogo, and J. K. Beckman, “Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion,” Kidney International, vol. 41, no. 4, pp. 1008–1015, 1992. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Schley, N. Cordasic, B. Klanke et al., Radiocontrast Nephropathy: Role of Endothelial Injury, and Chronic Consequences, ASN, Atlanta, Ga, USA, 2013.
  76. A. Khan, J. L. Maderdrut, M. Li et al., “Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model,” Physiological Reports, vol. 1, no. 6, article e00163, 2013. View at Publisher · View at Google Scholar
  77. Y. Zurovsky, “Models of glycerol-induced acute renal failure in rats,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 4, no. 3, pp. 213–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. S. B. Duan, Y. H. Wang, F. Y. Liu et al., “The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model,” Acta Radiologica, vol. 50, no. 7, pp. 754–759, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. K. E. Al-Otaibi, A. M. Al Elaiwi, M. Tariq, and A. K. Al-Asmari, “Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 831748, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. S.-B. Duan, F.-Y. Liu, J.-A. Luo et al., “Nephrotoxicity of high- and low-osmolar contrast media: the protective role of amlodipine in a rat model,” Acta Radiologica, vol. 41, no. 5, pp. 503–507, 2000. View at Google Scholar · View at Scopus
  81. A. Linkermann, J. O. Heller, A. Prokai et al., “The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice,” Journal of the American Society of Nephrology, vol. 24, no. 10, pp. 1545–1557, 2013. View at Google Scholar
  82. G.-H. Kim, “Renal effects of prostaglandins and cyclooxygenase-2 inhibitors,” Electrolyte and Blood Pressure, vol. 6, no. 1, pp. 35–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Deng, G. Wu, C. Yang, Y. Li, Q. Jing, and Y. Han, “Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats,” Journal of Translational Medicine, vol. 13, no. 1, article 53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. T.-Q. Liu, W.-L. Luo, X. Tan et al., “A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 427560, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Liu, Y. Fang, S. Liu et al., “Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β,” Free Radical Biology and Medicine, vol. 81, pp. 170–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. S.-K. Yang, S.-B. Duan, P. Pan, X.-Q. Xu, N. Liu, and J. Xu, “Preventive effect of pentoxifylline on contrast-induced acute kidney injury in hypercholesterolemic rats,” Experimental and Therapeutic Medicine, vol. 9, no. 2, pp. 384–388, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. D. A. Lauver, E. G. Carey, I. L. Bergin, B. R. Lucchesi, and H. S. Gurm, “Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury,” PLoS ONE, vol. 9, no. 11, Article ID e113598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Pettersson, R. Towart, D. Grant, K. Thyberg, and K. Golman, “The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents,” Academic Radiology, vol. 9, no. 1, pp. S62–S64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. S. N. Heyman, S. Rosen, and C. Rosenberger, “Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 1, pp. 288–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. J. A. Rees, S. L. Old, and P. C. Rowlands, “An ultrastructural histochemistry and light microscopy study of the early development of renal proximal tubular vacuolation after a single administration of the contrast enhancement medium ‘Iotrolan’,” Toxicologic Pathology, vol. 25, no. 2, pp. 158–164, 1997. View at Publisher · View at Google Scholar · View at Scopus
  91. Z. Ruben, D. C. Dodd, K. J. Rorig, and S. N. Anderson, “Disobutamide: a model agent for investigating intracellular drug storage,” Toxicology and Applied Pharmacology, vol. 97, no. 1, pp. 57–71, 1989. View at Publisher · View at Google Scholar · View at Scopus
  92. L. Yao, G. K. Kolluru, K. G. Christopher, and W. W. Zhang, “The gene expression of adenosine receptors in the processes of contrast induced nephropathy in mouse kidney,” Journal of Vascular Surgery, vol. 57, no. 5, pp. 80S–81S, 2013. View at Publisher · View at Google Scholar
  93. G. J. Becker and T. D. Hewitson, “Animal models of chronic kidney disease: useful but not perfect,” Nephrology Dialysis Transplantation, vol. 28, no. 10, pp. 2432–2438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Mekada, K. Abe, A. Murakami et al., “Genetic differences among C57BL/6 substrains,” Experimental Animals, vol. 58, no. 2, pp. 141–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Kiselycznyk and A. Holmes, “All (C57BL/6) mice are not created equal,” Frontiers in Neuroscience, vol. 5, Article ID 10, p. 10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Zheng, K. M. Schmidt-Ott, S. Chua et al., “A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 7, pp. 2502–2507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Kern, A. Knigge, J. T. Heiker et al., “C57BL/6JRj mice are protected against diet induced obesity (DIO),” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 717–720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. J. T. Heiker, A. Kunath, J. Kosacka et al., “Identification of genetic loci associated with different responses to high-fat diet-induced obesity in C57BL/6N and C57BL/6J substrains,” Physiological Genomics, vol. 46, no. 11, pp. 377–384, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Rendina-Ruedy, K. D. Hembree, A. Sasaki et al., “A comparative study of the metabolic and skeletal response of C57BL/6J and C57BL/6N mice in a diet-induced model of type 2 diabetes,” Journal of Nutrition and Metabolism, vol. 2015, Article ID 758080, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Qi, H. Fujita, J. Jin et al., “Characterization of susceptibility of inbred mouse strains to diabetic nephropathy,” Diabetes, vol. 54, no. 9, pp. 2628–2637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Walkin, S. E. Herrick, A. Summers et al., “The role of mouse strain differences in the susceptibility to fibrosis: a systematic review,” Fibrogenesis and Tissue Repair, vol. 6, no. 1, article 18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Zurita, M. Chagoyen, M. Cantero et al., “Genetic polymorphisms among C57BL/6 mouse inbred strains,” Transgenic Research, vol. 20, no. 3, pp. 481–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. C. D. Bryant, “The blessings and curses of C57BL/6 substrains in mouse genetic studies,” Annals of the New York Academy of Sciences, vol. 1245, no. 1, pp. 31–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. M. J. Burne, M. Haq, H. Matsuse, S. Mohapatra, and H. Rabb, “Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model,” Transplantation, vol. 69, no. 5, pp. 1023–1025, 2000. View at Google Scholar · View at Scopus
  105. X. Lu, N. Li, N. Shushakova et al., “C57BL/6 and 129/SV mice: genetic difference to renal ischemia-reperfusion,” Journal of Nephrology, vol. 25, no. 5, pp. 738–743, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. E. S. Harpur, D. Worah, P.-A. Hals, E. Holtz, K. Furuhama, and H. Nomura, “Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent,” Investigative Radiology, vol. 28, supplement 1, pp. S28–S43, 1993. View at Google Scholar · View at Scopus
  107. P. S. Randhawa, R. S. Saad, M. Jordan, V. Scantlebury, C. Vivas, and R. Shapiro, “Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization,” Transplantation, vol. 67, no. 1, pp. 85–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  108. J.-F. Moreau, D. Droz, L.-H. Noel, J. Leibowitch, P. Jungers, and J.-R. Michel, “Tubular nephrotoxicity of water-soluble iodinated contrast media,” Investigative Radiology, vol. 15, no. 6, supplement, pp. S54–S60, 1980. View at Publisher · View at Google Scholar · View at Scopus
  109. P. M. Treuting and J. Kowalewska, “Artefacts,” in A Practical Guide to the Histology of the Mouse, C. L. C. Scudamore, Ed., pp. 77–79, John Wiley & Sons, New York, NY, USA, 2014. View at Google Scholar
  110. P. Prentø and H. Lyon, “Commercial formalin substitutes for histopathology,” Biotechnic and Histochemistry, vol. 72, no. 5, pp. 273–282, 1997. View at Publisher · View at Google Scholar · View at Scopus
  111. R. C. Johnson, B. J. Dovey-Hartman, J. Syed et al., “Vacuolation in renal tubular epithelium of Cd-1 mice: an incidental finding,” Toxicologic Pathology, vol. 26, no. 6, pp. 789–792, 1998. View at Publisher · View at Google Scholar · View at Scopus
  112. Z. Ebcioglu, D. J. Cohen, R. J. Crew et al., “Osmotic nephrosis in a renal transplant recipient,” Kidney International, vol. 70, no. 10, pp. 1873–1876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. H. F. Helmholz, “Renal changes in the rabbit resulting from intravenous injection of hypertonic solution of sucrose,” The Journal of Pediatrics, vol. 3, no. 1, pp. 144–157, 1933. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Dickenmann, T. Oettl, and M. J. Mihatsch, “Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes,” American Journal of Kidney Diseases, vol. 51, no. 3, pp. 491–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. W. A. D. Anderson and W. R. Bethea Jr., “Renal lesions following administration of hypertonic solutions of sucrose: report of six cases,” The Journal of the American Medical Association, vol. 114, no. 20, pp. 1983–1987, 1940. View at Publisher · View at Google Scholar
  116. A. C. Allen, “Diseases of the tubules,” in The Kidney. Medical and Surgical Diseases, A. C. Allen, Ed., vol. diseases, pp. 207–298, Grune & Stratton, New York, NY, USA, 1951. View at Google Scholar
  117. A. Bendele, J. Seely, C. Richey, G. Sennello, and G. Shopp, “Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins,” Toxicological Sciences, vol. 42, no. 2, pp. 152–157, 1998. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Legendre, E. Thervet, B. Page, A. Percheron, L. H. Noël, and H. Kreis, “Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation,” The Lancet, vol. 342, no. 8865, pp. 248–249, 1993. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Jungheinrich and T. A. Neff, “Pharmacokinetics of hydroxyethyl starch,” Clinical Pharmacokinetics, vol. 44, no. 7, pp. 681–699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. E. A. J. Hoste and W. De Corte, “Implementing the Kidney Disease: improving global outcomes/acute kidney injury guidelines in ICU patients,” Current Opinion in Critical Care, vol. 19, no. 6, pp. 544–553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. E. I. Christensen and A. B. Maunsbach, “Dextran is resistant to lysosomal digestion in kidney tubules,” Virchows Archiv B Cell Pathology Including Molecular Pathology, vol. 37, no. 1, pp. 49–59, 1981. View at Publisher · View at Google Scholar · View at Scopus
  122. A. B. Maunsbach, S. C. Madden, and H. Latta, “Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran,” Laboratory Investigation, vol. 11, pp. 421–432, 1962. View at Google Scholar · View at Scopus
  123. A. Z. Nomani, Z. Nabi, H. Rashid et al., “Osmotic nephrosis with mannitol: review article,” Renal Failure, vol. 36, no. 7, pp. 1169–1176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. P. Liss, P. Hansell, P.-O. Carlsson, A. Fasching, and F. Palm, “Iodinated contrast media decrease renomedullary blood flow. A possible cause of contrast media-induced nephropathy,” Advances in Experimental Medicine and Biology, vol. 645, pp. 213–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. T. Nonoyama and R. Fukuda, “Drug-induced phospholipidosis—pathological aspects and its prediction,” Journal of Toxicologic Pathology, vol. 21, no. 1, pp. 9–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. H. A. Lindberg, M. H. Wald, and M. Barker, “Renal changes following administration of hypertonic solutions (50 per cent sucrose, 50 per cent d-sorbitol,* 50 per cent dextrose and 10 per cent sodium chloride),” Archives of Internal Medicine, vol. 63, no. 5, pp. 907–918, 1939. View at Publisher · View at Google Scholar
  127. G. Simon, F. Chatelanat, and A. Falbriard, “Experimental nephrosis due to inulin: light and electron microscopic studies,” Laboratory Investigation, vol. 13, pp. 1381–1393, 1964. View at Google Scholar · View at Scopus
  128. S. Hansen-Schmidt, J. Silomon, and F. Keller, “Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis,” American Journal of Kidney Diseases, vol. 28, no. 3, pp. 451–453, 1996. View at Publisher · View at Google Scholar · View at Scopus
  129. D. B. Winward and M. T. Brophy, “Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report,” Pharmacotherapy, vol. 15, no. 6, pp. 765–772, 1995. View at Google Scholar · View at Scopus
  130. Centers for Disease Control and Prevention, “Renal insufficiency and failure associated with immune globulin intravenous therapy—United States, 1985–1998,” Morbidity and Mortality Weekly Report, vol. 48, no. 24, pp. 518–521, 1999. View at Google Scholar
  131. B. Chacko, G. T. John, N. Balakrishnan, M. G. Kirubakaran, and C. K. Jacob, “Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy,” Renal Failure, vol. 28, no. 2, pp. 193–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. S. L. Schwartz and C. B. Johnson, “Pinocytosis as the cause of sucrose nephrosis,” Nephron, vol. 8, no. 3, pp. 246–254, 1971. View at Publisher · View at Google Scholar · View at Scopus
  133. G. Gluhovschi, F. Gadalean, C. Gluhovschi et al., “Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy,” Renal Failure, vol. 36, no. 4, pp. 534–540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. W. G. Guder and B. D. Ross, “Enzyme distribution along the nephron,” Kidney International, vol. 26, no. 2, pp. 101–111, 1984. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Hofmeister, A. S. Bhargava, and P. Günzel, “The use of urinary N-acetyl-β-D-glucosaminidase (NAG) for the detection of contrast-media-induced ‘osmotic nephrosis’ in rats,” Toxicology Letters, vol. 50, no. 1, pp. 9–15, 1990. View at Publisher · View at Google Scholar · View at Scopus
  136. E. Seeliger, M. Ladwig, L. Sargsyan, K. Cantow, P. B. Persson, and B. Flemming, “Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats,” Investigative Radiology, vol. 47, no. 4, pp. 240–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. B. Yang, J. Xu, F. Xu et al., “Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 1, Article ID e85029, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. G. Laurent, B. K. Kishore, and P. M. Tulkens, “Aminoglycoside-induced renal phospholipidosis and nephrotoxicity,” Biochemical Pharmacology, vol. 40, no. 11, pp. 2383–2392, 1990. View at Publisher · View at Google Scholar · View at Scopus
  139. M. R. Rudnick, J. S. Berns, R. M. Cohen, and S. Goldfarb, “Contrast media-associated nephrotoxicity,” Seminars in Nephrology, vol. 17, no. 1, pp. 15–26, 1997. View at Google Scholar · View at Scopus
  140. B. Ryffel, B. M. Foxwell, A. Gee, B. Greiner, G. Woerly, and M. J. Mihatsch, “Cyclosporine—relationship of side effects to mode of action,” Transplantation, vol. 46, no. 2, supplement, pp. 90S–96S, 1988. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Naesens, D. R. J. Kuypers, and M. Sarwal, “Calcineurin inhibitor nephrotoxicity,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 2, pp. 481–508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. P. Walday, I. F. Heglund, K. Golman, J. Cornacoff, and E. Holtz, “Renal effects of iodixanol in experimental animals,” Acta Radiologica. Supplementum, vol. 399, pp. 204–212, 1995. View at Google Scholar · View at Scopus
  143. M. Dobrota, C. J. Powell, E. Holtz, A. Wallin, and H. Vik, “Biochemical and morphological effects of contrast media on the kidney,” Acta Radiologica. Supplementum, vol. 399, pp. 196–203, 1995. View at Google Scholar · View at Scopus
  144. C. J. Powell, M. Dobrota, E. Holtz, and H. Vik, “The histopathology of X-ray contrast medium induced renal droplets (vacuoles),” European Radiology, vol. 5, no. 2, pp. 176–180, 1995. View at Publisher · View at Google Scholar · View at Scopus
  145. J. Wang, Y. Zhang, X. Yang et al., “Time course study on the effects of iodinated contrast medium on intrarenal water transport function using diffusion-weighted MRI,” Journal of Magnetic Resonance Imaging, vol. 35, no. 5, pp. 1139–1144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. Y.-D. Zhang, J. Wang, J. Zhang, X. Wang, and X. Jiang, “Effect of iodinated contrast media on renal function evaluated with dynamic three-dimensional MR renography,” Radiology, vol. 270, no. 2, pp. 409–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. Y. Zhang, J. Wang, X. Yang et al., “The serial effect of iodinated contrast media on renal hemodynamics and oxygenation as evaluated by ASL and BOLD MRI,” Contrast Media and Molecular Imaging, vol. 7, no. 4, pp. 418–425, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. J.-H. Wang, K. Ren, W.-G. Sun, L. Zhao, H.-S. Zhong, and K. Xu, “Effects of iodinated contrast agents on renal oxygenation level determined by blood oxygenation level dependent magnetic resonance imaging in rabbit models of type 1 and type 2 diabetic nephropathy,” BMC Nephrology, vol. 15, no. 1, article 140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  149. T. S. Larson, K. Hudson, J. I. Mertz, J. C. Romero, and F. G. Knox, “Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system,” The Journal of Laboratory and Clinical Medicine, vol. 101, no. 3, pp. 385–391, 1983. View at Google Scholar · View at Scopus
  150. R. O. Danford, L. B. Talner, and A. J. Davidson, “Effect of graded osmolaltities of saline solution and contrast media on renal extraction of pah in the dog,” Investigative Radiology, vol. 4, no. 5, pp. 301–305, 1969. View at Publisher · View at Google Scholar · View at Scopus
  151. W. A. Sorby and R. J. Hoy, “Renal arteriography and renal function. The short-term effect of aortography, selective renal arteriography, adrenalin suppression and renal venography on PAH extraction ratio,” Australasian Radiology, vol. 12, no. 3, pp. 252–255, 1968. View at Publisher · View at Google Scholar · View at Scopus
  152. C. B. Higgins, “Renal circulation,” in Radiocontrast Agents, M. Solioz, Ed., Springer, Berlin, Germany, 1984. View at Google Scholar
  153. C. Gospos, N. Freudenberg, J. Staubesand, K. Mathias, and X. Papacharlampos, “The effect of contrast media on the aortic endothelium of rats,” Radiology, vol. 147, no. 3, pp. 685–688, 1983. View at Publisher · View at Google Scholar · View at Scopus
  154. R. Battenfeld, A. E. R. Khater, W. Drommer, P. Guenzel, and F.-J. Kaup, “Ioxaglate–induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats,” Investigative Radiology, vol. 26, no. 1, pp. 35–39, 1991. View at Publisher · View at Google Scholar · View at Scopus
  155. C. J. Powell, M. Dobrota, and E. Holtz, “Studies on the mechanism of radiological contrast media induced renal failure,” in Nephrotoxicity, P. H. Bach and E. A. Lock, Eds., pp. 463–468, Springer US, 1989. View at Google Scholar
  156. S. W. Murphy, B. J. Barrett, and P. S. Parfrey, “Contrast nephropathy,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 177–182, 2000. View at Google Scholar · View at Scopus
  157. K. Hardiek, R. E. Katholi, V. Ramkumar, and C. Deitrick, “Proximal tubule cell response to radiographic contrast media,” American Journal of Physiology—Renal Physiology, vol. 280, no. 1, pp. F61–F70, 2001. View at Google Scholar · View at Scopus
  158. M. C. Heinrich, M. K. Kuhlmann, A. Grgic, M. Heckmann, B. Kramann, and M. Uder, “Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro,” Radiology, vol. 235, no. 3, pp. 843–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Haller, C. S. Schick, M. Zorn, and W. Kübier, “Cytotoxicity of radiocontrast agents on polarized renal epithelial cell monolayers,” Cardiovascular Research, vol. 33, no. 3, pp. 655–665, 1997. View at Publisher · View at Google Scholar · View at Scopus
  160. M. Heinrich, M. Scheer, M. Heckmann, W. Bautz, and M. Uder, “Reversibility and time-dependency of contrast medium induced inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) conversion in renal proximal tubular cells in vitro: comparison of a monomeric and a dimeric nonionic iodinated contrast medium,” Investigative Radiology, vol. 42, no. 11, pp. 732–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. C. S. Schick and C. Haller, “Comparative cyotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro,” Nephrology Dialysis Transplantation, vol. 14, no. 2, pp. 342–347, 1999. View at Publisher · View at Google Scholar · View at Scopus
  162. R. A. Zager, A. C. M. Johnson, and S. Y. Hanson, “Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity,” Kidney International, vol. 64, no. 1, pp. 128–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Romano, C. Briguori, C. Quintavalle et al., “Contrast agents and renal cell apoptosis,” European Heart Journal, vol. 29, no. 20, pp. 2569–2576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. H. D. Humes, D. A. Hunt, and M. D. White, “Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells,” American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 252, no. 2, pp. F246–F255, 1987. View at Google Scholar · View at Scopus
  165. D. S. Humes, D. A. Cieslinski, and J. M. Messana, “Pathogenesis of radiocontrast-induced acute renal failure: comparative nephrotoxicity of diatrizoate and iopamidol,” Diagnostic Imaging, vol. 9, 1987. View at Google Scholar
  166. A. Aurelio and A. Durante, “Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment,” Cardiology, vol. 128, no. 1, pp. 62–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  167. I. Hizóh, J. Sträter, C. S. Schick, W. Kübier, and C. Haller, “Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity,” Nephrology Dialysis Transplantation, vol. 13, no. 4, pp. 911–918, 1998. View at Publisher · View at Google Scholar · View at Scopus
  168. I. Hizoh and C. Haller, “Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress,” Investigative Radiology, vol. 37, no. 8, pp. 428–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  169. A. Peer, Z. Averbukh, S. Berman, D. Modai, M. Averbukh, and J. Weissgarten, “Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, endothelial, and hepatic cells,” Investigative Radiology, vol. 38, no. 3, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Quintavalle, M. Brenca, F. De Micco et al., “In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis,” Cell Death & Disease, vol. 2, no. 5, article e155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. S. N. Heyman, C. Rosenberger, and S. Rosen, “Experimental ischemia-reperfusion: biases and mythsthe proximal vs. distal hypoxic tubular injury debate revisited,” Kidney International, vol. 77, no. 1, pp. 9–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  172. T. Kaucsár, M. Godó, C. Révész et al., “Urine/plasma neutrophil gelatinase associated lipocalin ratio is a sensitive and specific marker of subclinical acute kidney injury in mice,” PLoS ONE, vol. 11, no. 1, article 0148043, 2016. View at Publisher · View at Google Scholar · View at Scopus
  173. L. Hofmann, S. Simon-Zoula, A. Nowak et al., “BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics,” Kidney International, vol. 70, no. 1, pp. 144–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  174. A. O. Oyekan, “Contributions of nitric oxide and prostanoids and their signaling pathways to the renal medullary vasodilator effect of U46619 (9-11-dideoxy-11 alpha,9a-epoxymethano-prostaglandin F(2a)) in the rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 2, pp. 507–512, 2003. View at Publisher · View at Google Scholar
  175. L. S. Chawla and P. L. Kimmel, “Acute kidney injury and chronic kidney disease: an integrated clinical syndrome,” Kidney International, vol. 82, no. 5, pp. 516–524, 2012. View at Publisher · View at Google Scholar · View at Scopus